Ascites - 119 Studies Found

Completed : North American Study for the Treatment of Refractory Ascites (NASTRA)
:
  • Ascites
  • Liver Cirrhosis

: 2000-08-08
:
  • Procedure: Transjugular intrahepatic portasystemic shunts (TIPS)
Completed : Study in EpCAM Positive Patients With Symptomatic Malignant Ascites Using Removab Versus an Untreated Control Group
:
  • EpCam Positive Tumor (e.g.Ovarian, Gastric, Colon, Breast)
  • Malignant A
    : 2009-02-03
    :
    • Biological: Catumaxomab (Removab)

Completed : Tolvaptan for Ascites in Cirrhotic Patients
:
  • Ascites
  • Cirrhosis

: 2011-02-07
: Drug: Tolvaptan Oral administration once daily Dosage will range from 15 mg to 30 mg
Completed : Bevacizumab as a Palliative Treatment for Patients With Symptomatic Malignant Ascites Due to Advanced-stage Gastrointestinal Cancers
:
  • Malignant Ascites
  • Gastrointestinal Cancers

: 2010-09-09
:
  • Drug: Bevacizumab Patients wil
Completed : Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS)
:
  • Ascites
  • Liver Cirrhosis

: 2006-07-31
:
  • Drug: Satavaptan oral administ
Recruiting : Results of CRS and Debulking in PMP Patients
: Pseudomyxoma Peritonei
: 2011-08-31
Recruiting : HIPEC Using High Intra-abdominal Pressure
:
  • Pseudomyxoma Peritonei
  • Colorectal Cancer

: 2016-10-07
:
  • Procedure: Cytoreductive surgery

Completed : Thrombin Generation and Platelet Activation in CRS/HIPEC
:
  • Mesothelioma; Peritoneum
  • Pseudomyxoma Peritonei
  • : 2017-01-12
    : Procedure: CRS/HIPEC The generic surgical approach involved peritonectomy procedures and visceral resect
Recruiting : Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed
:
  • Peritoneal Carcinomatosis
  • Pseudomyxoma Peritonei
  • : 2012-06-08
Recruiting : Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies
:
  • Pseudomyxoma Peritonei.
  • Colorectal Carcinoma.